Edition:
United States

Easton Pharmaceuticals Inc (EAPH.PK)

EAPH.PK on OTC Markets Group

0.03USD
--
Change (% chg)

-- (--)
Prev Close
$0.03
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,880,203
52-wk High
$0.06
52-wk Low
$0.00

Latest Key Developments (Source: Significant Developments)

Easton Pharmaceuticals Inc and BMV Medica finalize license agreement with CommonSense Ltd.
Tuesday, 4 Aug 2015 08:00am EDT 

Easton Pharmaceuticals Inc:Company and BMV have signed an agreement and made payment to Common Sense LTD of Israel.For exclusive rights to market and sell Common Sense's AL-Sense (Amniotic-Sense-Blue) Amniotic Fluid Leak Test for most of Latin America.  Full Article

Easton Pharmaceuticals Inc announces management change
Wednesday, 29 Jul 2015 08:00am EDT 

Easton Pharmaceuticals Inc:Says appointment of Evan Karras as CEO & Director and announces Nunzio Valerie as President /CFO.  Full Article

Easton Pharmaceuticals Inc announces finalized joint partnership agreement with BMV Medica
Wednesday, 22 Apr 2015 07:00am EDT 

Easton Pharmaceuticals Inc:Has entered into 50/50 revenue sharing partnership with BMV Medica SA de C.V.For an exclusive distribution agreement with Common Sense Ltd. of Israel to become exclusive distributor in the country of Mexico for their world patented woman's diagnostic Vaginal Infection Test, currently being sold throughout the United States, Canada and soon Europe.Both companies are pleased to say they have obtained exclusive distribution rights for country of Mexico from Israel-based Common Sense Ltd. and their world patented product line known as VS-SENSE-OTC and VS-SENSE PRO, for the detection of Bacterial Vaginosis (BV) and Trichomonas.BV is a common condition in which the natural balance of bacteria inside vagina becomes disrupted.One in three women will get BV at some point in their lifetime, which demonstrates the huge market and revenue capabilities for products.  Full Article

More From Around the Web

BRIEF-Easton Pharmaceuticals signs letter of intent to acquire iBliss Inc

* Easton Pharmaceuticals signs letter of intent to acquire major vaporizer and e-liquids manufacturer iBliss Inc. Source text for Eikon: Further company coverage:

No consensus analysis data available.